Evidence map›Paper›PMID 28050461›Full record

ArticleJournal of clinical and diagnostic research : JCDR2016

Role of

V Suganthi, A Gokul Das

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and diagnostic research : JCDR, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. The best type of probiotic for the prevention and treatment of neonatal physiological jaundice: A systematic review and meta-analysis.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2026
    Article
  7. Observational
  8. Article
  9. Effect ofMicroorganisms · 2024
    Review
  10. Article
  11. Roles of Probiotics in Reduction of Neonatal Jaundice in Term Newborns.Juntendo Iji zasshi = Juntendo medical journal · 2022
    Article
  12. The role of microbiota in neonatal hyperbilirubinemia.American journal of translational research · 2020
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

V SuganthiHead of Department, Department of Pediatrics, Coimbatore Medical College Hospital , Coimbatore, Tamil Nadu, India .
A Gokul DasPaediatrician, Taluk Hospital , Pattambi, Kerala, India .

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionProbiotics are known to reduce the severity of hyperbilirubinemia.

aimThis study was done to evaluate the effect of probiotic on neonatal hyperbilirubinemia in term neonates. MATERIALS AND

methodsA total of 181 healthy term neonates after birth were divided into a control group (n=95) and a treatment group (n=86) randomly and treated with placebo and probiotic (

resultsOn day 3, mean total serum bilirubin in control group among patient who has not developed clinical jaundice is 6.5mg% and in the treatment group is 5mg%. In patient with clinical jaundice, it is 13.6mg% in control group and 10.7mg% in the treatment group. The p-value was found to be <0.05 which is statistically significant. No obvious adverse reactions noted in either group.

conclusionProbiotics lowered the serum bilirubin level of healthy neonate with jaundice safely and significantly without any adverse reaction.

Indexed as

Enterohepatic circulationJaundiceNeonatePhototherapyProbiotics

Identifiers

PMID28050461
PMCPMC5198414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.